Spots Global Cancer Trial Database for Ulipristal Acetate 10 mg and Asisted Reproduction
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Ulipristal Acetate 10 mg and Asisted Reproduction
Official Title: Uterine Fibroids: Impact of Ulipristal Acetate 10 mg on ART Results
Study ID: NCT02425878
Study Description
Brief Summary: Demonstrate an 15% increase in the rate of clinical pregnancy in women with inoperable intramural fibroids not distorting the uterine cavity within a program OVD, after administration of uPA in a dose of 10 mg orally daily for 12 weeks
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
IVI Valencia, Valencia, , Spain
Contact Details
Name: Daniela Galliano, MDPhD
Affiliation: Instituto Valenciano de Infertilidad, IVI VALENCIA
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
